Skip to main content
Clinical Trials/NCT04323787
NCT04323787
Completed
Not Applicable

Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry and Validation of C2D2 (Critical Care Data Dictionary)

Mayo Clinic4 sites in 1 country100,000 target enrollmentMarch 30, 2020
ConditionsCoronavirus

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronavirus
Sponsor
Mayo Clinic
Enrollment
100000
Locations
4
Primary Endpoint
ICU and hospital mortality of COVID-19 patients
Status
Completed
Last Updated
last year

Overview

Brief Summary

Researchers are creating a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.

Detailed Description

Investigators aim is to create a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals. Such a set of standards would increase the quality of single and multi-center studies, national registries as well as aggregation syntheses such as meta-analyses. It will also be of utmost importance in tiring times of public health emergencies and will help understand practice variability and outcomes during COVID-19 pandemic.

Registry
clinicaltrials.gov
Start Date
March 30, 2020
End Date
March 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Juan Pablo Domecq Garces

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • COVID-19 PCR positive (within 7 days)
  • COVID-19 PCR pending
  • COVID-19 high clinical suspicion

Exclusion Criteria

  • Patient without Prior Research Authorization (applicable to Mayo Clinic sites)
  • Non COVID-19 related admissions
  • Repeated Admission to ICUs/Hospital

Outcomes

Primary Outcomes

ICU and hospital mortality of COVID-19 patients

Time Frame: 7 days

Primary outcome will be to measure ICU and hospital mortality up to 7 days of COVID-19 patients

Secondary Outcomes

  • 30 days mortality(30 days)

Study Sites (4)

Loading locations...

Similar Trials